Stock Events

Stock Events

Corvus Pharmaceuticals (C17.F) Q4 2025 Earnings

4NovConfirmed

Q4 2024

Q2 2025

Q3 2025

Q4 2025

-0.57

-0.41

-0.25

-0.09

Details

Expected EPS

-0.11052419238

Actual EPS

-0.1044792

Surprise EPS

0.01

Surprise Percent

+5.47%

Description

Corvus Pharmaceuticals (C17.F) has reported earnings of -0.1044792 per share for Q4 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.